跳至主要内容
临床试验/NL-OMON51677
NL-OMON51677招募中不适用

SIMBA study: Seven Tesla Imaging Biomarkers of Cognitive Outcomes after Treatment for Pediatric Brain Tumor - SIMBA study

Prinses Máxima Centrum voor Kinderoncologie0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 64(—)

入选标准

  • - Age between 6 and 23 years old
  • - Have been treated for a posterior fossa brain tumor with surgery/chemotherapy
  • only, focal proton radiotherapy, or cranial-spinal proton radiotherapy
  • - At least 6 months and up to 5 years after diagnosis, and completed treatment
  • - Able to complete MRI without anaesthesia

排除标准

  • - No signed informed consent (either by patient and/or parents/legal guardian)
  • - Insufficient knowledge of the Dutch language to perform the
  • neuropsychological assessment or complete questionnaires
  • - Significant visual, motor, or developmental problems and thus alternative
  • neuropsychological assessments would be needed (e.g., blindness, deafness,
  • profound developmental delay)
  • - MRI-specific exclusion criteria, such as metal implants. Screening for MRI
  • specific exclusion criteria will be done using the typical 7-Tesla MRI safety

研究者

发起方
Prinses Máxima Centrum voor Kinderoncologie

相似试验